Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Dr Reddy’s Laboratories ( (RDY) ) has shared an update.
On June 20, 2025, Dr. Reddy’s Laboratories announced its participation in upcoming investor conferences scheduled for June 25 and 26, 2025, in Hyderabad. These meetings, organized by B&K Securities and Avendus Spark, are set to be in-person group meets, providing an opportunity for the company’s management to engage with institutional investors. This engagement is part of Dr. Reddy’s ongoing efforts to maintain transparency and communication with stakeholders, potentially impacting investor relations and market perceptions positively.
The most recent analyst rating on (RDY) stock is a Buy with a $17.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.
Dr Reddy’s Laboratories’ strong financial performance is the most significant factor, underscored by consistent revenue growth and profitability. Technical analysis supports a favorable stock trend, although valuation is fair with modest income potential. The absence of earnings call and corporate events data did not impact the overall score.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is a prominent pharmaceutical company based in Hyderabad, India. It specializes in the development and manufacturing of a wide range of pharmaceutical products, focusing on generic medications, active pharmaceutical ingredients (APIs), and proprietary products. The company is listed on major stock exchanges, including the National Stock Exchange of India, BSE Limited, and the New York Stock Exchange.
Average Trading Volume: 2,114,557
Technical Sentiment Signal: Strong Buy
Current Market Cap: $12.64B
For an in-depth examination of RDY stock, go to TipRanks’ Overview page.